BUSINESS● LOWJul 31 · Jul 31, 2026, 12:45 PM
Sun Pharma misses Q1 estimates as US generics drag offsets India growth
livemint.com · India
Sun Pharma's first-quarter financial results fell short of estimates, primarily due to struggles in the US generics market despite growth in India. This report details the company's recent financial performance and market challenges.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from India
HEALTH1h agoKeralam considering sites in Thrissur, Kasaragod for proposed All-India Institute of AyurvedaThe HinduBUSINESS1h agoStellantis to invest ₹4,000 cr, plan 12 India launches, triple market share by 2030The HinduWORLD1h agoHindu temple shooting plot shocks Indian - Americansprokerala.com · IndiaBUSINESS1h agoFTAs - driven exports behind India recent growth upgrades by global agencies : Jayant Sinhaorlandoecho.com · United States
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS29m agoFranklin Universal Trust declares $0.0425 dividendSeeking Alpha TechBUSINESS30m agoInfantino Offers Apology But ‘No Answers’ At FIFA Meeting Over World Cup PlanChannels TV